drugset / Trial / NCT06549309
Trial of JMKX003801 in Healthy Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
To Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of JMKX003801 Administered Randomly, Double-blind, Placebo-controlled, Single-ascending Dose and Multiple-ascending Dose in Chinese Healthy Adult Participants
Timeline
- Start
- 2024-08-17
- Primary completion
- 2025-05-31
- Completion
- 2025-06-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | JMKX003801 | Unknown | — | — |
Indications
No indication recorded.